CyclophosphamideTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1765卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65888-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：131 / 131

相关论文

共 50 条

[21] AntineoplasticsTumour lysis syndrome: case report
Reactions Weekly, 2019, 1735 (1) : 38 - 38
[22] AtezolizumabTumour lysis syndrome: case report
Reactions Weekly, 2019, 1769 (1) : 74 - 74
[23] ImatinibTumour lysis syndrome: case report
Reactions Weekly, 2009, 1238 (1) : 18 - 18
[24] HydroxycarbamideTumour lysis syndrome: case report
Reactions Weekly, 2021, 1863 (1) : 180 - 180
[25] RuxolitinibTumour lysis syndrome: case report
Reactions Weekly, 2017, 1671 (1) : 347 - 347
[26] CytarabineTumour lysis syndrome: case report
Reactions Weekly, 2016, 1589 (1) : 76 - 76
[27] AntineoplasticsTumour lysis syndrome: case report
Reactions Weekly, 2010, 1307 (1) : 13 - 13
[28] VenetoclaxTumour lysis syndrome: case report
Reactions Weekly, 2020, 1787 (1) : 478 - 478
[29] IpilimumabTumour lysis syndrome: case report
Reactions Weekly, 2017, 1644 (1) : 167 - 167
[30] CrizotinibTumour lysis syndrome: case report
Reactions Weekly, 2017, 1660 (1) : 123 - 123

← 1 2 3 4 5 →